United Therapeutics (UTHR) Tops Q3 EPS by 57c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.97 --0%
Revenue Growth %: -1.2%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CULP, KFY, NNOX, More
Revenue Growth %: -1.2%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
CULP, KFY, NNOX, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $4.16, $0.57 better than the analyst estimate of $3.59. Revenue for the quarter came in at $444.7 million versus the consensus estimate of $421.45 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Morgan Stanley Downgrades Vend Marketplaces (VEND:NO) to Equalweight
- B.Riley Starts Better Home & Finance Holding (BETR) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
